Renal Cell Carcinoma Metastatic Clinical Trial
Official title:
An Open-label, Multicenter Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of JMKX003948 Tablets in Patients With Renal Cell Carcinoma
This open-label Phase 1 study will evaluate the safety, tolerability, PK characteristics and preliminarily efficacy of JMKX003948 tablets in patients with renal cell carcinoma.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05548621 -
A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)
|
||
| Recruiting |
NCT04659343 -
TDM for Optimized Outcome in Patients With mRCC.
|
||
| Terminated |
NCT06377722 -
Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer
|
Phase 2 | |
| Completed |
NCT06161233 -
Pilot Study of the eHealth Application "Cancer Patients Better Life Experience" (CAPABLE) - Italy
|
N/A | |
| Recruiting |
NCT04764487 -
A Web-mediated Follow-up With the Web-application KidneyPRO Versus Standard Follow-up for Patients With Advanced Renal Cell Carcinoma Treated With Axitinib/Pembrolizumab in First Line
|
Phase 3 | |
| Active, not recruiting |
NCT03905889 -
A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma
|
Phase 1 | |
| Recruiting |
NCT03977571 -
Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial
|
N/A | |
| Completed |
NCT03699579 -
Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC
|
||
| Terminated |
NCT05103722 -
Combined Aerobic and Resistance Exercise Training in Metastatic Renal Cell Carcinoma
|
N/A |